Related Experiment Videos
The cost effectiveness of oral rehydration therapy for U.S. children with acute diarrhea
Insights
Diarrheal disease in young U.S. children causes significant health burdens. Implementing oral rehydration therapy (ORT) programs could save the U.S. healthcare system nearly $1 billion annually.
Area of Science:
- Pediatrics
- Public Health
- Health Economics
Background:
- Diarrheal disease is a leading cause of illness in US children under five.
- This condition places a substantial financial strain on the healthcare system.
- Oral rehydration therapy (ORT) is an underutilized, cost-effective treatment for diarrhea.
Purpose of the Study:
- To quantify the financial burden of childhood diarrhea in the United States.
- To evaluate the economic benefits of widespread Oral Rehydration Therapy (ORT) program implementation.
Main Methods:
- A decision-analysis model was employed to assess costs and benefits.
- The study focused on children under five years of age in the U.S.
Main Results:
- Childhood diarrhea represents a significant financial burden on the U.S. healthcare system.
- Comprehensive ORT programs demonstrate considerable economic advantages.
Conclusions:
- Increased utilization of ORT programs can lead to substantial cost savings.
- Full implementation of ORT programs could save the U.S. healthcare system approximately $1 billion annually.
Abstract:
Diarrheal disease is a common cause of morbidity among U.S. children under five years of age and exerts a heavy burden on the health care system. Oral rehydration therapy (ORT), a simple, inexpensive treatment modality that can prevent most diarrhea-related complications, is grossly underutilized in the United States. Using a decision-analysis model, this article describes the financial burden of childhood diarrhea in the United States for children under five years of age and discusses the substantial economic benefits of ORT programs. If fully implemented, such programs would save our health care system close to $1 billion annually.